Viewing Study NCT02280759


Ignite Creation Date: 2025-12-24 @ 2:38 PM
Ignite Modification Date: 2026-01-20 @ 12:22 PM
Study NCT ID: NCT02280759
Status: COMPLETED
Last Update Posted: 2017-07-06
First Post: 2014-10-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children.
Sponsor: Medical University of Warsaw
Organization:

Study Overview

Official Title: Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children: A Double Blind Randomized, Placebo- Controlled Trial .
Status: COMPLETED
Status Verified Date: 2017-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Gelatin tannate possesses astringent, antibacterial, and anti-inflammatory properties. It is increasingly being marketed as an antidiarrheal drug. A randomized, double blind, placebo-control trial was performed to assess the effectiveness of GT in management of children with acute gastroenteritis.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: